June 28, 2022 Comments Off on New patent expiration for Boehringer Ingelheim drug PRADAXA Posted in: Uncategorized
Annual Drug Patent Expirations for PRADAXA Pradaxa is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from four suppliers. There are five patents…
The post New patent expiration for Boehringer Ingelheim drug PRADAXA…
June 27, 2022 Comments Off on New patent expiration for Genzyme Corp drug CAPRELSA Posted in: Uncategorized
Annual Drug Patent Expirations for CAPRELSA Caprelsa is a drug marketed by Genzyme Corp and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Genzyme Corp drug CAPRELSA appeared first…